Gyre Therapeutics, Inc. (GYRE) on GreekSoup https://greeksoup.ai/stocks/us/gyre/ Every dated entry in the public record on Gyre Therapeutics, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Fri, 30 Oct 2026 00:00:00 +0000 Gyre Therapeutics, Inc. filed 8-K: officer or director changehttps://greeksoup.ai/stocks/us/gyre/filings/us:GYRE:filing:2026-10-22:e2d2f9bcf5Thu, 22 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Gyre Therapeutics, Inc.: short interest 1,927,774 shares at the 15 October 2026 settlement, 16.30 days to coverhttps://greeksoup.ai/stocks/us/gyre/short-interest/us:GYRE:short-interest:2026-10-15:de6ed36e2cThu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Gyre Therapeutics, Inc.: short interest 1,918,512 shares at the 30 September 2026 settlement, 6.92 days to coverhttps://greeksoup.ai/stocks/us/gyre/short-interest/us:GYRE:short-interest:2026-09-30:2296d4bf0eWed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Gyre Therapeutics, Inc.: short interest 1,730,215 shares at the 15 September 2026 settlement, 19.22 days to coverhttps://greeksoup.ai/stocks/us/gyre/short-interest/us:GYRE:short-interest:2026-09-15:35b5968294Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Gyre Therapeutics, Inc. filed 8-K: regulation fd disclosurehttps://greeksoup.ai/stocks/us/gyre/filings/us:GYRE:filing:2026-09-01:6206f2649cTue, 01 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Gyre Therapeutics, Inc.: short interest 1,709,352 shares at the 31 August 2026 settlement, 34.43 days to coverhttps://greeksoup.ai/stocks/us/gyre/short-interest/us:GYRE:short-interest:2026-08-31:ed3f23d3afMon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Gyre Therapeutics, Inc. filed S-8: s-8https://greeksoup.ai/stocks/us/gyre/filings/us:GYRE:filing:2026-08-27:2cc62bd5b4Thu, 27 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Gyre Therapeutics, Inc. filed 8-K: regulation fd disclosurehttps://greeksoup.ai/stocks/us/gyre/filings/us:GYRE:filing:2026-08-26:1d8c2b80b8Wed, 26 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Gyre Therapeutics, Inc.: short interest 1,745,865 shares at the 14 August 2026 settlement, 31.05 days to coverhttps://greeksoup.ai/stocks/us/gyre/short-interest/us:GYRE:short-interest:2026-08-14:a247ac4da7Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Gyre Therapeutics, Inc. Q2 FY2026 results: revenue $29 million, net income -$14 millionhttps://greeksoup.ai/stocks/us/gyre/results/fy2026-q2/us:GYRE:result:2026-08-07:3545320281Fri, 07 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Gyre Therapeutics, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/gyre/filings/us:GYRE:filing:2026-08-07:5c1314a13fFri, 07 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Gyre Therapeutics, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/gyre/filings/us:GYRE:filing:2026-08-07:c43270bff7Fri, 07 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]>